Literature DB >> 27403007

DPP-4 Inhibitors: The Seinfeld of Oral Antihyperglycemics.

Arden R Barry1, Ricky D Turgeon2.   

Abstract

Entities:  

Year:  2016        PMID: 27403007      PMCID: PMC4924948          DOI: 10.4212/cjhp.v69i3.1564

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


× No keyword cloud information.
  4 in total

1.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

2.  Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

Authors:  William B White; Christopher P Cannon; Simon R Heller; Steven E Nissen; Richard M Bergenstal; George L Bakris; Alfonso T Perez; Penny R Fleck; Cyrus R Mehta; Stuart Kupfer; Craig Wilson; William C Cushman; Faiez Zannad
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

3.  Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Jennifer B Green; M Angelyn Bethel; Paul W Armstrong; John B Buse; Samuel S Engel; Jyotsna Garg; Robert Josse; Keith D Kaufman; Joerg Koglin; Scott Korn; John M Lachin; Darren K McGuire; Michael J Pencina; Eberhard Standl; Peter P Stein; Shailaja Suryawanshi; Frans Van de Werf; Eric D Peterson; Rury R Holman
Journal:  N Engl J Med       Date:  2015-06-08       Impact factor: 91.245

4.  Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis.

Authors:  Haesuk Park; Chanhyun Park; Yoona Kim; Karen L Rascati
Journal:  Ann Pharmacother       Date:  2012-11-07       Impact factor: 3.154

  4 in total
  3 in total

1.  Should All Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Receive an SGLT2 Inhibitor?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2018-08-28

2.  Newer Oral Antihyperglycemics: From Seinfeld to Breaking Bad.

Authors:  Arden R Barry; Ricky D Turgeon
Journal:  Can J Hosp Pharm       Date:  2019-10-21

3.  Influence of nutritional intervention on children with type 1 diabetes mellitus and DPP-4 in serum.

Authors:  Yan-Jun Dong; Li-Juan Liu; Hui-Ming Chen; Jing Sun; Ming-Hua Xiao; Jin-Hui Wu
Journal:  Exp Ther Med       Date:  2017-06-09       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.